Abstract 4079: EVT801: a selective VEGFR3 inhibitor with the potential for combination with immune-checkpoint therapies, preclinical evidences and plans for first-in-human evaluation
DOI: 10.1158/1538-7445.AM2019-4079
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Pierre Fons; Michael Esquerre; Michael Paillasse; Virgile Visentin; Frederique Dol; Jerome Meneyrol; Gaelle Badet; Eric Cogo; Lionel Vidaud; Antoine Alam; Isabelle Blanc; Francoise Bono; Joanna Lisztwan; Muriel Poublanc; Thomas Filleron; Ian Hunneyball; Jean-Pierre Delord; Mark Whittaker
全文下载地址: https://aacrjournals.org/cancerres/article/79/13_Supplement/4079/636032/Abstract-4079-EVT801-a-selective-VEGFR3-inhibitor